Correlation Between Reviva Pharmaceuticals and Aravive
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Aravive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Aravive into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Aravive, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Aravive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Aravive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Aravive.
Diversification Opportunities for Reviva Pharmaceuticals and Aravive
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Reviva and Aravive is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Aravive in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aravive and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Aravive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aravive has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Aravive go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and Aravive
Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to generate 1.59 times more return on investment than Aravive. However, Reviva Pharmaceuticals is 1.59 times more volatile than Aravive. It trades about 0.01 of its potential returns per unit of risk. Aravive is currently generating about -0.83 per unit of risk. If you would invest 487.00 in Reviva Pharmaceuticals Holdings on September 12, 2024 and sell it today you would lose (235.00) from holding Reviva Pharmaceuticals Holdings or give up 48.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 1.14% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. Aravive
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| Aravive |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Reviva Pharmaceuticals and Aravive Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and Aravive
The main advantage of trading using opposite Reviva Pharmaceuticals and Aravive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Aravive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aravive will offset losses from the drop in Aravive's long position.| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |